MedTrace Logo

Evaluation of Cell-mediated Immune Response by QuantiFERON Monitor® Assay in Kidney Transplant Recipients

NCT03488771 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2018-04-05

No results posted yet for this study

Summary

All kidney transplant recipients require immunosuppression, the net level of which is difficult to assess. Current practice in assessing immune reactivity is to monitor levels of some immunosuppressive drugs. QuantiFERON Monitor® (QFM) is an in vitro diagnostic test that detects interferon-γ (IFN-γ) release in peripheral blood. Its clinical utility in assessment of the net state of immunosuppression in kidney transplant recipients has not been well studied. The aim of our study is to evaluate the discriminating value of QFM testing results for infection and rejection in a single-centre cohort of kidney transplant recipients.

Conditions

  • Kidney Transplant Infection
  • Kidney Transplant Rejection

Sponsors & Collaborators

  • Clinical Hospital Centre Zagreb

    collaborator OTHER

  • Clinical Hospital Merkur

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-05
Primary Completion
2018-06-01
Completion
2018-12-01

Countries

  • Croatia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03488771 on ClinicalTrials.gov